The startup utilizes genetically modified Black Soldier Flies (Hermetia illucens) to produce human insulin and other recombinant proteins at scale, significantly reducing the cost of growth media for cultivated meat. Additionally, the company offers genetic modification services tailored for the global BSF industry, enhancing production efficiency and sustainability.
Funding
$3.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
The production of recombinant proteins, such as human insulin, is often expensive due to the high cost of growth media required for traditional cell-based manufacturing. This cost barrier limits the scalability and affordability of these essential biopharmaceuticals.
Solution
This startup leverages genetically modified Black Soldier Flies (BSF) as a novel biomanufacturing platform for producing human insulin and other recombinant proteins at a significantly reduced cost. By utilizing BSF larvae as bioreactors, the company overcomes the limitations of traditional cell culture methods, offering a scalable and cost-effective alternative. The BSF platform reduces the reliance on expensive growth media, making biopharmaceutical production more accessible and sustainable. Furthermore, the company provides genetic modification services to enhance BSF production efficiency for other players in the insect farming industry.
Target Audience
The primary customers are pharmaceutical companies and biomanufacturers seeking cost-effective and scalable solutions for producing recombinant proteins, as well as Black Soldier Fly farms looking to improve production efficiency through genetic modification.
Features
- Genetically engineered Black Soldier Flies for high-yield production of recombinant proteins
- Scalable BSF larvae-based biomanufacturing platform
- Significantly reduced growth media costs compared to traditional cell culture
- Genetic modification services to enhance BSF production efficiency
- Circular biomanufacturing approach